This profile was last updated on .
Is this you? Claim your profile.
The Ottawa Hospital
1053 Carling Ave.
The Ottawa Hospital is a multi-campus academic health sciences centre. With over 1000 beds, 10,000 staff plus 1200 physicians, and an annual operating budget of approximately $600 million, it is one of the largest healthcare organizations in Canada. In co...
Find other employees at this company (6,164)
(134 Total References)
Leadership & Members | Department of Medicine in Ottawa
Previously, therapies for those with ...
Previously, therapies for those with hepatitis C were "difficult" with "really serious side effects," such as fatigue, weight loss, headaches, poor sleep and mental health issues, said Dr. Curtis Cooper, the director of Ottawa Hospital and Regional Hepatitis Program, in a phone interview with Yahoo Canada. On top of the side effects, the treatments required injections for a period of 24 to 48 weeks.
Dr. Curtis Cooper is currently an Associate Professor with the University of Ottawa, Infectious Diseases Consultant with the Ottawa Hospital Division of Infectious Diseases, and Associate Clinical Researcher with the Ottawa Hospital Research Institute.
As a clinical researcher, his
research activities encompass HIV
, viral hepatitis, and vaccine development.
work is focused on the development of new therapeutic agents and the delivery of treatment that maximizes safety, adherence and safety.
Curtis is an OHTN Career Scientist and Core Co-leader of the CTN Co-infections and concurrent diseases core.
OHTN Research Conference
- Curtis Cooper
Associate Professor, University of Ottawa, Infectious Diseases Consultant with the Ottawa Hospital Division of Infectious Diseases
View the 2013 Conference Archive
would like to thank our conference co-chairs - Fanta Ongoiba and Curtis Cooper
- and the members of the abstract review committee who helped develop the conference program by reviewing more than 180 abstract submissions.
Curtis Cooper, MD, ...
Curtis Cooper, MD, FRCPC
Dr. Cooper trained at the University of Saskatchewan, receiving his medical degree in 1994.
received certifications in Internal Medicine in 1997 and in Infectious Diseases in 1999 while at the University of Manitoba
He completed an HIV Research Fellowship and a master's degree in Epidemiology in 2002 at the University of Ottawa.
Dr. Cooper's current titles include Associate Professor with the University of Ottawa, Scientist with the Ottawa Hospital Research Institute, Infectious Diseases Consultant with the Ottawa Hospital Division of Infectious Diseases, and Director of The Ottawa Hospital Viral Hepatitis Program, and he holds an Applied HIV Research Chair with the Ontario HIV Treatment Network (OHTN).
Dr. Cooper is also co-chair of the CIHR Canadian HIV Trials Network Co-infection and Concurrent Diseases Research Core and an executive board member of the Canadian Association of HIV Researchers.